Get notified when SPTX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: SPTX Seaport Therapeutics, Inc. 8-K

Seaport Therapeutics reports Q1 2026 financial results

Filed June 8, 2026 · Period ending June 8, 2026 · ~1 min read

Key Changes

  • medium

    Company announced financial results for the three months ended March 31, 2026 via press release. Specific financial metrics and performance data are contained in the attached exhibit.

    Item 2.02 verify on EDGAR →
  • low

    This is a routine quarterly earnings disclosure filed under Item 2.02 (Results of Operations and Financial Condition). The 8-K itself contains no financial details beyond the announcement.

    8-K: Earnings verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (THRM 10-Q) is open in full — no account needed.

Partner

Trade SPTX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 9, 2026 · How we verify